TA
Taro Pharma
TARO·NYSEHaifa ILFounded 19593,000 employees
Mid CappharmaPublicDermatology
Platform: Generic Derm
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (TARO)
Loading TARO stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TAR-8916 | TAR-8916 | Phase 1 | 1 | LAG-3 | SCD | ||
| Sovafutibatinib | TAR-7505 | NDA/BLA | 2 | WEE1 | LN | ||
| TAR-1794 | TAR-1794 | NDA/BLA | 1 | CD20 | ObesityCSU |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)